- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Fast Growing Stocks With High Insider Ownership
U.S. Pharmaceuticals & Biotech Fast Growing Stocks With High Insider Ownership
Results
17
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
17 companies
OS Therapies
Market Cap: US$76.2m
A clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States.
OSTX
US$2.39
7D
-3.6%
1Y
-42.3%
Corcept Therapeutics
Market Cap: US$7.3b
Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.
CORT
US$69.72
7D
-0.9%
1Y
97.5%
Grace Therapeutics
Market Cap: US$41.9m
Engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada.
GRCE
US$3.03
7D
-6.8%
1Y
15.6%
Eton Pharmaceuticals
Market Cap: US$464.2m
A pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.
ETON
US$17.31
7D
0.06%
1Y
276.3%
TuHURA Biosciences
Market Cap: US$135.1m
A clinical stage immuno-oncology company, that develops novel technologies for the treatment of cancer immunotherapies.
HURA
US$2.70
7D
-16.9%
1Y
n/a
Liquidia
Market Cap: US$2.4b
A biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States.
LQDA
US$27.68
7D
3.1%
1Y
191.1%
TriSalus Life Sciences
Market Cap: US$260.3m
Engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers.
TLSI
US$5.22
7D
3.4%
1Y
-0.6%
BioRestorative Therapies
Market Cap: US$14.7m
Develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells.
BRTX
US$1.84
7D
20.3%
1Y
12.2%
Krystal Biotech
Market Cap: US$4.3b
A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.
KRYS
US$147.70
7D
-1.9%
1Y
-24.3%
Protalix BioTherapeutics
Market Cap: US$123.6m
A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system.
PLX
US$1.55
7D
-6.6%
1Y
64.2%
Clene
Market Cap: US$53.1m
A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics.
CLNN
US$5.32
7D
-6.0%
1Y
0.9%
Journey Medical
Market Cap: US$189.7m
Focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
DERM
US$7.21
7D
-3.5%
1Y
44.8%
Harrow
Market Cap: US$1.4b
An eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products.
HROW
US$39.00
7D
-0.3%
1Y
-3.6%
Celcuity
Market Cap: US$2.2b
A clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States.
CELC
US$51.23
7D
-2.3%
1Y
221.0%
Aprea Therapeutics
Market Cap: US$9.1m
A clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways.
APRE
US$1.57
7D
-4.9%
1Y
-54.4%
Niagen Bioscience
Market Cap: US$791.2m
Operates as a bioscience company engages in developing healthy aging products.
NAGE
US$9.90
7D
-0.8%
1Y
187.0%
Organogenesis Holdings
Market Cap: US$653.3m
A regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States.
ORGO
US$5.15
7D
5.3%
1Y
78.8%